Frank Boess

4.7k citations

45 papers · 3.0k indexed · 1 hit paper · h-index 24

Cellular and Molecular Neuroscience top 1%
- Neurotransmitter Receptor Influence on Behavior 12
- Neuroscience and Neuropharmacology Research 6
Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases 5
Molecular Biology top 5%
- Receptor Mechanisms and Signaling 12
- Nicotinic Acetylcholine Receptors Study 11
Biological Psychiatry top 10%
Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 4
Organic Chemistry
- Chemical synthesis and alkaloids 7

Co-authors: Ian L. Martin Viktor Lakics Eric Karran Andrew J. Sleight Anne Bourson Michael Bös Rudy Schreiber Jos Prickaerts
Cited by: Cellular and Molecular Neuroscience Pharmacology Molecular Biology
Journals: Neuropharmacology (6 papers)Journal of Neurochemistry (4 papers)Alzheimer s & Dementia (3 papers)
Partner nations: Switzerland Germany United Kingdom

In The Last Decade

Frank Boess

45 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Frank Boess

Since Specialization

Citations

This map shows the geographic impact of Frank Boess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Boess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Boess more than expected).

Fields of papers citing papers by Frank Boess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Boess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Boess. The network helps show where Frank Boess may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frank Boess, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Boess Line = papers co-authored together Frank Boess links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease JAMA Neurology ·Joseph Jankovic,Ira Goodman,Beth Safirstein,Tonya Marmon,Dale B. Schenk,Martin Koller,Wagner Zago,Daniel Ness,Sue G. Griffith,Michael Grundman,Jay Soto,Susanne Ostrowitzki,Frank Boess,Meret Martin‐Facklam,Joseph F. Quinn,Stuart Isaacson,Omid Omidvar,Aaron Ellenbogen,Gene G. Kinney	2018	224
2	Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice Journal of Diabetes and its Complications ·Dan Ziegler,Edith Schneider,Frank Boess,Lovisa Berggren,Frank Birklein	2014	18
3	Adherence to Initial PDE5 Inhibitor Treatment: Randomized OpenLabel Study Comparing Tadalafil Once a Day, Tadalafil on Demand, and Sildenafil on Demand in Patients with Erectile Dysfunction The Journal of Sexual Medicine ·Irène Buvat,Hartwig Büttner,Konstantinos Hatzimouratidis,Pedro Vendeira,Ignacio Moncada,J. Sandherr,Carsten Henneges,Frank Boess	2013	28
4	Effectiveness of Duloxetine Compared With Pregabalin and Gabapentin in Diabetic Peripheral Neuropathic Pain Clinical Journal of Pain ·Michael Happich,Edith Schneider,Frank Boess,Stefan Wilhelm,Alexander Schacht,Frank Birklein,Dan Ziegler	2013	29
5	EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors Neuropharmacology ·Jos Prickaerts,Nick P. van Goethem,Richard Chesworth,Gideon Shapiro,Frank Boess,Christoph Methfessel,吴丽莉,Dorothy G. Flood,Dana Hilt,Maria S. Gawryl,Sonia Bertrand,Daniel Bertrand,Gerhard König	2011	174
6	Use of behavioural and long-term potentiation models in the development of memory-improving drugs Expert Opinion on Drug Discovery ·Arjan Blokland,Frank Boess	2008	3
7	Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance Neuropharmacology ·Frank Boess,Martin Hendrix,F. Josef van der Staay,Christina Erb,Rudy Schreiber,Tuti Wiyati,Jan de Vente,Jos Prickaerts,Arjan Blokland,Gerhard Koenig	2004	251
8	AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors Psychopharmacology ·Marja van Kampen,Akmal Muamar. D. R,Renate Schneider,Domenico Sebastiani,Frank Boess,Rudy Schreiber	2004	140
9	Importance of Phenylalanine 107 in Agonist Recognition by the 5-Hydroxytryptamine3A Receptor Molecular Pharmacology ·Lucinda J. Steward,Frank Boess,J J Klynhout,I. Dalmau Mena,M Hocini,Ian L. Martin	2000	38
10	Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT₆ receptors British Journal of Pharmacology ·Andrew J. Sleight,Frank Boess,Michael Bös,Bernard Levet‐Trafit,Claus Riemer,Anne Bourson	1998	150
11	The Putative 5‐ht₆ Receptor: Localization and Function Annals of the New York Academy of Sciences ·Andrew J. Sleight,Frank Boess,Michael Bös,Anne Bourson	1998	34
12	Identification of Residues in Transmembrane Regions III and VI that Contribute to the Ligand Binding Site of the Serotonin 5‐HT₆ Receptor Journal of Neurochemistry ·Frank Boess,Frederick J. Monsma,Andrew J. Sleight	1998	37
13	The 5-Hydroxytryptamine6 Receptor-Selective radioligand [3H]Ro 63–0563 Labels 5-Hydroxytryptamine Receptor Binding Sites in Rat and Porcine Striatum Molecular Pharmacology ·Frank Boess,Claus Riemer,Michael Bös,Tamara K. Shirokova,Anne Bourson,Andrew J. Sleight	1998	62
14	5-HT 6 and 5-HT 7 Receptors: Molecular Biology, Functional Correlates and Possible Therapeutic Indications. Drug News & Perspectives ·Andrew J. Sleight,Frank Boess,Anne Bourson,David R. Sibley,Frederick J. Monsma	1997	12
15	Analysis of the Ligand Binding Site of the 5-HT 3 Receptor Using Site Directed Mutagenesis: Importance of Glutamate 106 Neuropharmacology ·Frank Boess,Lucinda J. Steward,J J Klynhout,I. Dalmau Mena,Joanne Reid,Thora A. Glencorse,Ian L. Martin	1997	61
16	Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor Molecular Pharmacology ·Frank Boess,Frederick J. Monsma,Aleksandr Migrov,Catherine Zwingelstein,Andrew J. Sleight	1997	29
17	Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice Naunyn-Schmiedeberg s Archives of Pharmacology ·Anne Bourson,Martine Verdier,Catherine Zwingelstein,Alina Krivitky Aalam,Frank Boess,Andrew J. Sleight	1997	48
18	Functional and Radioligand Binding Characterization of Rat 5-HT 6 Receptors Stably Expressed in HEK293 Cells Neuropharmacology ·Frank Boess,Frederick J. Monsma,Rojanee Homchalee,Aleksandr Migrov,Alina Krivitky Aalam,Catherine Zwingelstein,Andrew J. Sleight	1997	74
19	Ultrastructure of the 5‐Hydroxytryptamine₃ Receptor Journal of Neurochemistry ·Frank Boess,Rameen Beroukhim,Ian L. Martin	1995	107
20	Molecular Properties of 5‐Hydroxytryptamine3 Receptor‐Type Binding Sites Purified from NG1O8‐15 Cells Journal of Neurochemistry ·Frank Boess,Sarah C. R. Lummis,Ian L. Martin	1992	29

About Frank Boess

Frank Boess is a scholar working on Cellular and Molecular Neuroscience, Neurology, Pharmacology, Cognitive Neuroscience and Clinical Psychology, having authored 45 papers that have together received 3.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (12 papers), Neurotransmitter Receptor Influence on Behavior (12 papers), Nicotinic Acetylcholine Receptors Study (11 papers), Chemical synthesis and alkaloids (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neurological disorders and treatments (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.4k citations), Pharmacology (658 citations), Molecular Biology (1.9k citations), Biological Psychiatry (61 citations) and Neurology (318 citations). Frank Boess has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Ian L. Martin, Viktor Lakics, Eric Karran, Andrew J. Sleight, Anne Bourson, Michael Bös, Rudy Schreiber, Jos Prickaerts, Rameen Beroukhim and F. Josef van der Staay. Their work appears in journals such as Neuropharmacology, Journal of Neurochemistry, Alzheimer s & Dementia, Molecular Pharmacology and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact